Phase 2 Study of Efficacy, Safety and Tolerability of R05186582 in Adults with Adolescents with Down Syndrome (Clematis)
Administered By
Awarded By
Contributors
- Kishnani, Priya Sunil Principal Investigator
Start/End
- April 15, 2014 - April 14, 2016